Regenerative Medicine

How Stem Cell Therapy Differs From the Peptides People Are Taking

August 21, 2026

“Peptides” gets used as if it describes one thing, and that’s part of what makes this comparison confusing. It doesn’t. Insulin is a peptide. So is a hormone your own body makes every day. Others, including some compounds marketed online for wellness or recovery, have limited human safety data and have drawn specific concerns from the FDA. Stem cell therapy is a genuinely different category of biology altogether: cells rather than molecules. It also comes with its own regulatory picture, which is more layered than many articles on this topic let on. This is meant as a straightforward, educational comparison of the two, not a case for one over the other.

The Short Answer

Peptides are short chains of amino acids that can act as biological signals. Some peptides are FDA-approved medications that have been used for decades. Others, including compounds such as BPC-157, TB-500, and CJC-1295, are not FDA-approved for the treatment of specific conditions and have different regulatory and safety considerations that vary by substance. Their regulatory and compounding status can also evolve over time.

Stem cell therapy involves living cells rather than signaling molecules, and its regulatory picture is also more layered than it first appears. Some human cell and tissue products may be regulated solely under Section 361 of the Public Health Service Act when they meet all applicable criteria, including requirements related to minimal manipulation and homologous use. Products that do not meet those criteria may instead be regulated as drugs, biologics, or other regulated products and may require premarket review before they can be legally marketed for that use.

Understanding which category a specific substance or product actually falls into matters more than knowing whether it’s a “peptide” or a “stem cell” at all.

What Are Peptides?

Peptides are short sequences of amino acids, smaller than proteins, that can act as biological messengers. Your body produces peptides constantly to regulate processes such as insulin release, blood pressure, and digestion. Because the category is so broad, peptides can have very different regulatory and clinical profiles.

FDA-approved peptide medications include insulin, GLP-1 receptor agonists such as semaglutide and liraglutide, oxytocin, calcitonin, and glucagon, among others. These medications have undergone FDA review and are prescribed for specific, approved indications.
Peptides with more complicated regulatory status include compounds such as BPC-157, TB-500, and CJC-1295. These substances are not FDA-approved for the treatment of specific conditions and carry their own regulatory and safety considerations. FDA has identified limited or no human safety information for some of these substances and has raised specific concerns about certain compounds. The agency has also been evaluating questions surrounding the compounding of certain peptide substances.

The point isn’t that peptides are inherently risky or inherently safe. It’s that “is this peptide FDA-approved?” is a question with a different answer for each specific compound and product. It’s worth asking about the exact substance in question rather than the category as a whole.

What Is Stem Cell Therapy?

Stem cell therapy refers broadly to approaches that involve administering or transplanting living cells for therapeutic purposes. Cells may come from a patient’s own body (autologous) or from donated tissue (allogeneic), depending on the specific therapy. Researchers have studied stem cells and other cell-based approaches for their potential effects on tissue repair, inflammation, and other biological processes, but clinical evidence varies substantially depending on the specific cell product and condition being treated.

It’s important to understand what current regulatory status actually covers, and what it doesn’t. Not every stem cell or tissue-based product on the market has been evaluated and approved by the FDA for the purposes for which it is marketed. The FDA has stated that regenerative medicine therapies have not been approved to treat orthopedic conditions such as osteoarthritis, tendonitis, back pain, knee pain, or shoulder pain. The agency has also taken enforcement action against clinics and manufacturers over products and marketing claims that it determined did not meet applicable regulatory requirements.

That’s a meaningful distinction to understand before considering any specific product, regardless of who’s offering it.

Why the Regulatory Picture Is More Layered Than It Sounds

Some human cell and tissue products may be regulated solely under Section 361 of the Public Health Service Act when they meet all applicable criteria. These criteria include requirements related to minimal manipulation and homologous use, as well as other requirements concerning how the product is manufactured and used.

Minimal manipulation generally concerns whether processing alters the original relevant characteristics of the tissue or the relevant biological characteristics of cells or nonstructural tissues. Homologous use generally means that the product is intended to perform the same basic function or functions in the recipient that it performed in the donor.

Products that do not meet the applicable criteria may instead be regulated as drugs, biologics, devices, or combinations of regulated products and may require premarket review before they can be legally marketed for a particular use.

Peptide products are subject to a different regulatory framework, including FDA requirements governing approved drugs and, where applicable, compounded drugs. In both categories, the answer to “is this properly regulated?” depends on the specific product, how it is manufactured or processed, and its intended use, not simply on whether it is broadly described as a “peptide” or “stem cell” therapy.

How Stem Cell Therapy Differs From the Peptides People Are Taking

How the Two Actually Work, at a Basic Level

Beyond regulatory status, the two categories work differently at a basic level. Peptides can act as biological signals by interacting with specific receptors or other molecular targets, but their effects, duration, and dosing schedules vary substantially depending on the specific peptide. Broad generalizations about “how peptides work” don’t hold up well across such a diverse category.

A living cell is a fundamentally different kind of biological material. Cells can respond to signals from their surrounding environment and may interact with multiple biological processes. Researchers continue to study how different cell types behave in different settings, but the strength of clinical evidence varies considerably depending on the specific cell product, condition, and method of use.

Questions Worth Asking, Regardless of Which Option You’re Considering

Is this specific substance or product FDA-approved for the specific use being discussed, not just “regulated” in some general sense?
What does current, peer-reviewed evidence actually say about this substance or therapy for your specific condition, as opposed to anecdotal or marketing claims?
Who is sourcing, processing, and administering it, and under what oversight?
Has your physician reviewed your full medical history in the context of this specific option?

Frequently Asked Questions

Are all peptides unapproved or unsafe?

No. Many peptides, including insulin and several GLP-1 medications, are FDA-approved and widely prescribed. Others, particularly certain wellness and recovery-focused compounds, are not FDA-approved for the treatment of specific conditions and have a different evidence and safety profile. The two shouldn’t be lumped together.

Is stem cell therapy FDA-approved for joint pain or arthritis?

FDA states that regenerative medicine therapies have not been approved to treat orthopedic conditions such as osteoarthritis, tendonitis, back pain, knee pain, or shoulder pain. FDA approval status can vary by the specific product and its intended use, so patients should ask exactly what product is being offered and what, if any, FDA approval applies to it.

What does “minimally manipulated” mean?

Minimal manipulation refers to whether processing alters the original relevant characteristics of the tissue or the relevant biological characteristics of cells or nonstructural tissues. Whether a specific product qualifies depends on the particular tissue or cells and how they are processed, not simply on whether the product is prepared in an injectable form.

How can I evaluate whether a specific therapy is appropriate for me?

Ask directly about the FDA approval or regulatory status of the specific product involved, review what peer-reviewed evidence actually exists for your condition, and talk with your physician about your full medical history before making a decision.

Have Questions About Stem Cell Therapy?

Interested in learning more about stem cell therapy? Contact Dynamic Stem Cell Therapy to discuss your questions and treatment options. Our team can walk through what’s currently known, what remains under study, and what to ask as you weigh your options.

This article is for general educational purposes only and is not a substitute for medical advice. Treatment decisions should be made in consultation with a qualified healthcare professional.

Contents show